Dylan Morris

Dylan Morris is a Managing Director at Insight Partners since 2021 and holds multiple Board Director positions across various companies, including Exsilio Therapeutics, Superluminal Medicines Inc., ImmuneBridge, Profluent Bio, Unlearn.AI, Gameto, Capacity Bio, and DEM Biopharma, Inc., all of which commenced in 2022 or 2023. Additionally, Dylan serves as a Board Director for ArrePath since 2021. Dylan holds a Graduate Research degree in Biochemistry and Molecular Biophysics from Caltech and an AB in Computer Science from Harvard University.